Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 3 |
2013 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Interaction of Val66Met BDNF and 5-HTTLPR polymorphisms with prevalence of post-earthquake 27-F PTSD in Chilean population.
PeerJ. 2023 Sep 4;11:e15870. doi: 10.7717/peerj.15870. eCollection 2023.
PeerJ. 2023.
PMID: 37692110
Free PMC article.
CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers.
Llerena A, Dorado P, Ramírez R, Calzadilla LR, Peñas-Lledó E, Álvarez M, Naranjo ME, González I, Pérez B; CEIBA Consortium of Ibero–American Network of Pharmacogenetics & Pharmacogenomics RIBEF.
Llerena A, et al.
Pharmacogenomics. 2013 Dec;14(16):1973-7. doi: 10.2217/pgs.13.181.
Pharmacogenomics. 2013.
PMID: 24279852
Item in Clipboard
Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender.
Dorado P, Beltrán LJ, Machín E, Peñas-Lledó EM, Terán E, Llerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF.
Dorado P, et al.
Pharmacogenomics. 2012 Nov;13(15):1711-7. doi: 10.2217/pgs.12.160.
Pharmacogenomics. 2012.
PMID: 23171336
Item in Clipboard
Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
Rodeiro I, Remírez-Figueredo D, García-Mesa M, Dorado P, LLerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF.
Rodeiro I, et al.
Drug Metabol Drug Interact. 2012;27(1):57-60. doi: 10.1515/dmdi-2012-0006.
Drug Metabol Drug Interact. 2012.
PMID: 22718626
Item in Clipboard
Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes.
Dorado P, Machín E, de Andrés F, Naranjo ME, Peñas-Lledó EM, Llerena A; CEIBA.FP Consortium for the Ibero-American Network of Pharmacogenomics RIBEF.
Dorado P, et al.
Drug Metabol Drug Interact. 2012;27(4):217-33. doi: 10.1515/dmdi-2012-0018.
Drug Metabol Drug Interact. 2012.
PMID: 23093260
Item in Clipboard
Cite
Cite